Juno Therapeutics
    Industry / private company
    
    
        Location: 
        Göttingen,
        
                Germany (DE)
                
    
 
        
    
    
    
        ROR: https://ror.org/01zv88x17
    
    
    
    
    
        
    
        
    
        
    
    
    
        
            
                
  
  A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity (2020)
  Roex MCJ, Hageman L, Veld SAJ, Van Egmond E, Hoogstraten C, Stemberger C, Germeroth L, et al.
  Journal article
            
                
  
  Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study (2020)
  Roex MCJ, Van Balen P, Germeroth L, Hageman L, Van Egmond E, Veld SAJ, Hoogstraten C, et al.
  Journal article
            
                
  
  Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function (2019)
  Schober K, Mueller TR, Goekmen F, Grassmann S, Effenberger M, Poltorak M, Stemberger C, et al.
  Journal article, Original article